about
Strategies of temozolomide in future glioblastoma treatmentDendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis.Efficacy of bevacizumab therapy for unresectable malignant glioma: A retrospective analysis.Propyl Gallate Exerts an Antimigration Effect on Temozolomide-Treated Malignant Glioma Cells through Inhibition of ROS and the NF-κB Pathway.Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma.Enhancement of Antiangiogenic Efficacy of Iron(II) Complex by Selenium Substitution.Therapeutic Immunization against Glioblastoma
P2860
Q28817303-4B5CA66F-2B80-40CE-B7E7-A73E0520464EQ36201736-0CEA78ED-3C3B-424C-BBA6-BE835A4EB4D8Q37593916-EEBAA73E-DB80-4282-B0A9-861899D048E7Q42976697-C0D708FD-2FD5-41D5-AAEF-061245D7592AQ48515806-16C290D9-F8DA-4B5A-889A-EE29C353DCADQ48822702-40495B21-92FB-4BFA-A964-53ECDDC0985EQ58700123-F2BD1E4A-FED0-43F7-92DC-349810EB158E
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Bevacizumab for glioblastoma
@ast
Bevacizumab for glioblastoma
@en
Bevacizumab for glioblastoma
@nl
type
label
Bevacizumab for glioblastoma
@ast
Bevacizumab for glioblastoma
@en
Bevacizumab for glioblastoma
@nl
prefLabel
Bevacizumab for glioblastoma
@ast
Bevacizumab for glioblastoma
@en
Bevacizumab for glioblastoma
@nl
P2860
P3181
P356
P1476
Bevacizumab for glioblastoma
@en
P2093
Yoshitaka Narita
P2860
P304
P3181
P356
10.2147/TCRM.S58289
P407
P577
2015-01-01T00:00:00Z